Category: Press Release - Page 4 - Psychedelic Alpha

Read more about the article Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder

Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder

Post published:September 6, 2023
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH

Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH

Post published:September 6, 2023
Post category:Press Release

Read more about the article PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine) to the FDA

PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine) to the FDA

Post published:September 6, 2023
Post category:Press Release

Read more about the article COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

Post published:September 6, 2023
Post category:Press Release

Read more about the article BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement

BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement

Post published:September 5, 2023
Post category:Press Release

Read more about the article Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

Post published:September 5, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA

FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA

Post published:August 31, 2023
Post category:Press Release

Read more about the article COMPASS Pathways to participate in upcoming September investor conferences

COMPASS Pathways to participate in upcoming September investor conferences

Post published:August 29, 2023
Post category:Press Release

Read more about the article Sunstone Therapies in Collaboration with the University of Vermont Announces Publication of Study Showing Feasibility of Direct Observation of Therapeutic Connection in Psilocybin-Assisted Therapy

Sunstone Therapies in Collaboration with the University of Vermont Announces Publication of Study Showing Feasibility of Direct Observation of Therapeutic Connection in Psilocybin-Assisted Therapy

Post published:August 25, 2023
Post category:Press Release

Read more about the article GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates

GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates

Post published:August 23, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.